CN108002999B - Naphthalene compound and preparation method and application thereof - Google Patents

Naphthalene compound and preparation method and application thereof Download PDF

Info

Publication number
CN108002999B
CN108002999B CN201711067095.9A CN201711067095A CN108002999B CN 108002999 B CN108002999 B CN 108002999B CN 201711067095 A CN201711067095 A CN 201711067095A CN 108002999 B CN108002999 B CN 108002999B
Authority
CN
China
Prior art keywords
compound
silica gel
naphthalene compound
strain
culture medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201711067095.9A
Other languages
Chinese (zh)
Other versions
CN108002999A (en
Inventor
杜刚
杨海英
胡秋芬
詹梦涛
胡秋月
刘赟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yunnan Minzu University
Original Assignee
Yunnan Minzu University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yunnan Minzu University filed Critical Yunnan Minzu University
Priority to CN201711067095.9A priority Critical patent/CN108002999B/en
Publication of CN108002999A publication Critical patent/CN108002999A/en
Application granted granted Critical
Publication of CN108002999B publication Critical patent/CN108002999B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C07C45/79—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C07C45/80—Separation; Purification; Stabilisation; Use of additives by liquid-liquid treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
    • C12P7/26—Ketones

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention discloses a naphthalene compound and a preparation method and application thereof. The naphthalene compound is obtained by fermenting, extracting, chromatographing and purifying a Phomopsis fukushii strain, and the molecular formula of the naphthalene compound is C14H14O6The structural formula is as follows:
Figure 100004_DEST_PATH_IMAGE002
the compound was named: naphthalide D; the strain of Phomopsis Fukushii has the preservation number of CCTCC M2017632 and the preservation date of 10 months and 23 days in 2017. The preparation method takes a solid fermentation product of Phomopsis fukushii strain as a raw material, and comprises the steps of organic solvent extraction, silica gel column chromatography and high-pressure liquid chromatography separation. The application is the application of the naphthalene compound in preparing a methicillin-resistant staphylococcus aureus medicament. The compound has the advantages of novel structure, good activity and good application prospect.

Description

Naphthalene compound and preparation method and application thereof
Technical Field
The invention belongs to the technical field of biology, and particularly relates to a naphthalene compound and a preparation method and application thereof.
Background
With the long-term, non-standard use of antibiotics, drug-resistant bacteria have become a global problem; the most serious of them is methicillin-resistant staphylococcus aureus (MRSA), which is a growing nosocomial infection; klevens et al reported that more than 9 million people were expected to be infected with this deadly super pathogen in the United states each year in 2005, with nearly 1.9 million people dying, with a 2-fold increase in this data over the U.S. centers for disease control and prevention (CDC) report in 2001. MRSA has great treatment difficulty and high fatality rate, is combined with hepatitis B and AIDS as three infectious diseases in the world, and becomes one of the global public health problems. In 1978, medical staff randomly examined 200 strains of staphylococcus aureus in Shanghai, and the isolated MRSA was less than 5%. A sampling survey of hospitalized patients in 2009 showed that methicillin-resistant staphylococcus aureus (MRSA) was over 60%, increasing by 40% compared to 2000. The DNA of the intestinal flora of Chinese, Denmark and Spain was sequenced by Zhu Bao Li and co-workers at the institute of microbiology, university of Chinese medical science, and the study showed that: chinese intestinal flora has more drug-resistant genes. Therefore, the research and development of new strategies and new drugs capable of effectively controlling drug-resistant bacterial infection become a hotspot of antibiotic research.
Disclosure of Invention
The first purpose of the invention is to provide a naphthalene compound; the second purpose is to provide a preparation method of the naphthalene compound; the third purpose is to provide the application of the naphthalene compound.
The first purpose of the invention is realized by that the naphthalene compound is obtained by fermenting, extracting, chromatographing and purifying a Phomopsis fukushi strain, and the molecular formula of the naphthalene compound is C15H16O6The structural formula is as follows:
Figure DEST_PATH_IMAGE002
the compound was named: naphthalide D;
the second object of the present invention is achieved by comprising the steps of:
A. solid fermentation: culturing a strain Phomopsis fukushii in a potato glucose agar culture medium at 28 ℃ for 7 days, inoculating the strain to a triangular flask containing 10-100 ml of a liquid seed culture medium and 50-500 ml, performing shake culture at 28 ℃ for 5-10 days under the condition of rotary shake at a rotating speed of 180rpm to obtain a bacterium-containing nutrient medium, and inoculating the bacterium-containing nutrient medium to a rice solid culture medium to perform culture to obtain a fermentation product;
B. extracting the extractum: adding an organic solvent with the solid-liquid volume ratio of 1.5-3 times into the fermentation product, performing ultrasonic extraction for 2-4 times, each time for 2-6 hours, combining the extracting solutions, filtering, performing reduced pressure concentration until the volume is 1/4-1/2, standing, filtering out precipitates, and concentrating to obtain an extract;
C. silica gel column chromatography: performing silica gel column chromatography on the extract, wherein silica gel filled in the column is 200-300 meshes, and the using amount of the silica gel is 6-8 times of the weight of the extract; gradient eluting with a mixed organic solvent at a volume ratio of 20: 1-1: 1, collecting gradient eluent, concentrating, monitoring by TLC, and combining the same parts;
D. high-pressure liquid chromatography separation and purification: and (3) separating and purifying an eluent obtained by eluting the mixed organic solvent with the ratio of 6:4 by silica gel column chromatography and preparative high performance liquid chromatography to obtain the target naphthalene compound, namely naphthalide D.
The structure of the naphthalene compound of the present invention is determined by the following method:
the compounds of the invention are yellow gums; ultraviolet spectrum (the solvent is methanol),λ max(logε) 330(3.60),264 (3.06), 212 (3.76) nm; infrared spectrum (Potassium bromide tablet)ν max: 3422, 3065, 2954, 2768,1685, 1620, 1542, 1438, 1356, 1172, 1280, 1157, 1069, 1022cm-1(ii) a HRESIMS shows the molecular ion peak m/z of the inventive compound plus sodium301.0681 [M+Na]+（C14H14NaO6Calculated 301.0688), combined1H and13the C NMR spectrum (FIGS. 2 and 3, data attribution Table-1) gives the formula C14H14O6。
Compound (I)Is/are as follows1H and13c NMR spectrum shows that the compound has 14 carbon signals and 13 hydrogen signals, including 1,2,3,6,8-5 substituted naphthalene ring signals [ C-1 (C-1)d C166.9 s），C-2（d C106.8 s），C-3（d C156.2 s），C-4（d C101.5 d），C-4a（d C138.6 s），C-5（d C98.8 d），C-6（d C164.3 s），C-7（d C103.5 d），C-8（d C159.0 s），C-8a（d C105.4 s）; H-4（d H6.49 s）， H-5（d H6.55 d，J=2.2），H-7（d H6.31 d，J=2.2）]A methoxy signal [ OMe ] (d C56.1 q;d H3.81 s)]Three phenolic hydroxyl signals [ Ar-OH-1 ] (d H12.72 s），Ar-OH-3（d H11.89 s），Ar-OH-8（d H11.60 s）]A 3-hydroxypropionyl group [ C-1' ((C-1))d C205.7 s），C-2'（d C42.4 t），C-3'（d C61.7 t）；H2-2'（d H3.36 tJ=6.2），H2-3'（d H4.37 tJ=6.2）]. The infrared spectrum showed hydroxyl (3422 cm)-1) Carbonyl group (1685 cm)-1) And phenyl (1620,1542,1438 cm)-1) The absorption peak of (1). The UV spectrum absorbs at 330,264 and 212 nm indicating the presence of an extended chromophore and aromatic rings. H-4 (6.49 s) and C-2 (C-2) in HMBC spectrad C106.8 s）/ C-3（d C156.2 s）/C-5（d C98.8 d）/C-4a（d C138.6s）/C-8a（d C105.4 s），H-5（6.55 d，J= 2.2) and C-4 (C: (C-4)d C101.5 d）/C-6（d C164.3 s）/C-7（d C103.5 d）/C-4a（d C138.6 s）, H-7（6.31 d，J= 2.2) and C-5 (C: (C-5)d C98.8 d）/C-6（d C164.3 s）/C-8（d C159.0 s）/C-8a（d C105.4 s) confirmed the 5-membered substituted naphthalene ring in the compoundAnd (5) structure. H2-2′(δ H3.36) and C-2 (δ C106.8) correlation, confirming the attachment of the 3-hydroxypropionyl group at the C-2 position, OMe (C-2) ((C-2)δ H3.81) and C-6 (Cδ C164.3) correlation, confirming that the methoxy group is attached at the C-6 position, Ar-OH proton: (δ H12.72) and C-1 (C: (1:)δ C166.9)/C-2 (δ C106.8)/ C-8a (δ C105.4) related, Ar-OH proton ((Ar-OH)δ H11.60) and C-7 (δ C103.5)/C-8 (δ C159.0)/ C-8a (δ C105.4) related, Ar-OH proton ((Ar-OH)δ H11.89) and C-2 (Cδ C106.8)/C-3 (δ C156.2)/ C-4 (δ C101.5) correlation confirmed that three phenolic hydroxyl groups were attached at the C-1, C-8 and C-3 positions, respectively. The structure of the compound was thus confirmed.
Of the compounds of Table 11H and13c NMR data (solvent CDCl)3）
Figure DEST_PATH_IMAGE004
The third purpose of the invention is realized by the application of the naphthalene compound in preparing medicines for resisting methicillin-resistant staphylococcus aureus.
In recent years, the focus of research has turned back to the search for new secondary metabolites of the skeleton from microorganisms with different antibacterial mechanisms, and endophytic fungal metabolites are the most attractive hot spots in this field, among which the groups most frequently producing antibacterial active compounds are Phomopsis (Phomopsis), Phoma (Phoma) and Fusarium (Fusarium). The phomopsis is a large genus of fungi of Deuteromycotina and coelomycetes, and the strain can produce rich secondary metabolite, and Weber and the like are separated from erythrina cristataPhomopsissp. to obtain a new antibacterial activity lactone compound phomol, which shows good antibacterial activity to 24 bacteria and fungi by biological tests. Horn et al isolated from Salix integraPhomopsis sp.Strain, isolated cytochalasinThe alkaloid phomopsichalasin can inhibit Staphylococcus aureus, Pseudomonas aeruginosa, Bacillus subtilis, Staphylococcus luteus, and Escherichia coli.
The compound is separated for the first time, and the molecular formula and the structure of the compound are determined through nuclear magnetic resonance, mass spectrum, infrared spectrum and ultraviolet spectrum data. The activity of the compound against methicillin-resistant staphylococcus aureus is tested by a trace broth dilution method, and the MIC of the compound is 8 mu g/ml, which shows that the compound has better activity against methicillin-resistant staphylococcus aureus and can be used as a lead compound against methicillin-resistant staphylococcus aureus.
Drawings
FIG. 1 shows the NMR spectrum of a compound (A)1H NMR）；
FIG. 2 is a nuclear magnetic resonance carbon spectrum of a compound (C13C NMR）；
FIG. 3 is a graph of the correlation of compounds.
Detailed Description
The present invention is further illustrated by the following examples and the accompanying drawings, but the present invention is not limited thereto in any way, and any modifications or alterations based on the teaching of the present invention are within the scope of the present invention.
The naphthalene compound is obtained by fermenting, extracting, chromatographing and purifying Phomopsis fukushii strain, and the molecular formula of the naphthalene compound is C15H16O6The structural formula is as follows:
Figure 572415DEST_PATH_IMAGE002
the compound was named: naphthalide D;
said phomopsis formosana (A), (B), (C), (Phomopsis fukushii) The strain has the preservation number of CCTCC M2017632 and the preservation date of 2017, 10 months and 23 days.
The preparation method of the naphthalene compound comprises the following steps:
A. solid fermentation: culturing a strain Phomopsis fukushii in a potato glucose agar culture medium at 28 ℃ for 7 days, inoculating the strain to a triangular flask containing 10-100 ml of a liquid seed culture medium and 50-500 ml, performing shake culture at 28 ℃ for 5-10 days under the condition of rotary shake at a rotating speed of 180rpm to obtain a bacterium-containing nutrient medium, and inoculating the bacterium-containing nutrient medium to a rice solid culture medium to perform culture to obtain a fermentation product;
B. extracting the extractum: adding an organic solvent with the solid-liquid volume ratio of 1.5-3 times into the fermentation product, performing ultrasonic extraction for 2-4 times, each time for 2-6 hours, combining the extracting solutions, filtering, performing reduced pressure concentration until the volume is 1/4-1/2, standing, filtering out precipitates, and concentrating to obtain an extract;
C. silica gel column chromatography: performing silica gel column chromatography on the extract, wherein silica gel filled in the column is 200-300 meshes, and the using amount of the silica gel is 6-8 times of the weight of the extract; gradient eluting with a mixed organic solvent at a volume ratio of 20: 1-1: 1, collecting gradient eluent, concentrating, monitoring by TLC, and combining the same parts;
D. high-pressure liquid chromatography separation and purification: and (3) separating and purifying an eluent obtained by eluting the mixed organic solvent with the ratio of 6:4 by silica gel column chromatography and preparative high performance liquid chromatography to obtain the target naphthalene compound, namely naphthalide D.
The potato glucose agar culture medium in the step A is prepared by 200g/L of potatoes, 20g/L of glucose, 20g/L of agar, 6.5 of pH value, sterilization at 121 ℃ for 25min, and cooling to 60 ℃ to prepare an inverted slope.
The liquid seed culture medium in the step A is NaNO32g/L，K2HPO41g/L，MgSO4·7H2O 0.5g/L，KCL 0.5g/L，FeSO4·7H2O0.01 g/L, glucose 20g/L, pH 6.5, and sterilizing at 121 deg.C for 25min in a 250mL conical flask or 100 mL/flask.
The rice solid culture medium in the step A is prepared by filling 100g of rice, 20g of perlite and 100mL of distilled water into a 600mL tissue culture bottle, and sterilizing at 121 ℃ for 25 min.
And the organic solvent in the step B is acetone, ethanol or methanol with the volume concentration of 60-80%.
And C, before the extractum is subjected to silica gel column chromatography, dissolving the extractum by using methanol with the weight ratio of 1.5-3 times, and then mixing the extractum by using 80-200-mesh silica gel with the weight ratio of 1-3 times.
And C, the mixed organic solvent is chloroform-methanol.
The volume ratio of the mixed organic solvent is 20:1, 9:1, 8:2, 7:3, 6:4 and 5: 5.
The application of the naphthalene compound is the application of the naphthalene compound in preparing a methicillin-resistant staphylococcus aureus medicament.
The invention is further illustrated by the following specific examples:
example 1
(1) Inoculating phomopsis Fuji CCTCC M2017632 preserved in the slant solid culture medium to a plate of the slant solid culture medium for activation, and inoculating to the slant solid culture medium for storage after purification. The slant solid culture medium is as follows: 200g/L of potato, 20g/L of glucose, 20g/L of agar, 6.5 of pH value, 121 ℃, 25min of sterilization, cooling to 60 ℃, and pouring a flat plate and a bevel for standby;
(2) transferring the stored phomopsis Fuzicola CCTCC M2017632 into a liquid seed culture medium, and culturing at 28 ℃ for 24h on a shaking bed at the rotating speed of 180r/min to obtain phomopsis Fuzicola seed liquid. The liquid seed culture medium is as follows: NaNO32g/L，K2HPO41g/L，MgSO4·7H2O 0.5g/L，KCL 0.5g/L，FeSO4·7H20.01g/L of O, 20g/L of glucose and 6.5 of pH value, and the mixture is filled into a 250mL conical flask and a 100mL conical flask, sterilized for standby at 121 ℃ for 25 min;
(3) and (3) taking the phomopsis formosana seed liquid obtained in the step (2), inoculating the phomopsis formosana seed liquid into a rice solid culture medium according to the mass ratio of 2% of the culture medium, and performing solid fermentation at the fermentation temperature of 25 ℃, wherein the fermentation is completed in 35 days. The rice culture medium is as follows: 100g of rice, 20g of perlite and 100mL of distilled water are put into a 600mL tissue culture bottle and sterilized for standby at 121 ℃ for 25 min.
(4) Taking 10kg of fermentation product of phomopsis formosana CCTCC M2017632, ultrasonically extracting with 80% ethanol for 3 times, each time for 1h, combining the extracting solutions, filtering, and concentrating under reduced pressure to obtain extract A1120 g; adding equal volume of ethyl acetate into the extract A for extraction for 5 times, combining the extract phases, and concentrating under reduced pressure to obtain 141g of extract B.
(5) Dissolving the extract B with methanol, mixing with 200g of 80-mesh silica gel, loading into a 160-mesh silica gel column with 1500g of column, performing chromatographic separation, performing gradient washing with chloroform-methanol solutions with volume ratios of 20:1, 9:1, 8:2, 7:3, 6:4 and 5:5, collecting eluates of each part respectively, concentrating, and monitoring by TLC to combine the same parts.
(6) And (3) further separating 10.1g of the chloroform-methanol 6:4 elution concentrated part in the step (5) by using a high performance liquid chromatography, taking 47% methanol mobile phase and a C18 prepared chromatographic column (20X 250mm,20 mL/min) semi-preparative column as a stationary phase, taking an ultraviolet detection wavelength of 254nm, collecting chromatographic peaks for 10.2min, and evaporating to dryness after multiple accumulation to obtain yellow jelly.
Example 2
Example 1 was repeated with the following differences:
(1) ultrasonically extracting with 70% ethanol for 3 times, each time for 2 hr; the extract A after decompression concentration is 1020 g; and (5) decompressing and concentrating the extract B122 g.
(2) And mixing the extract B with 200g of 160-mesh silica gel.
(3) The chloroform-methanol 6:4 eluate fraction was 9.2g, and high performance liquid chromatography was performed using 49% methanol as the mobile phase to collect the chromatographic peak at 9.1 min.
Example 3
Example 1 was repeated with the following differences:
(1) ultrasonic extracting with 75% ethanol for 3 times; 1090g of extract A after decompression and concentration; the extract B obtained by vacuum concentration is 132 g.
(2) The chloroform-methanol 6:4 elution fraction was 10.3g, and 52% methanol was used as the mobile phase, and the chromatographic peak was collected for 8.5 min.
Example 4
Example 1 was repeated with the following differences:
(1) and mixing the extract B with 200g of 100-mesh silica gel.
(2) The chloroform-methanol 6:4 eluate fraction was 11.6g, and high performance liquid chromatography was performed using 55% methanol as the mobile phase to collect the chromatographic peak at 7.8 min.
Example 5
The compound prepared in example 1 was taken as a yellow gum and determined as follows: nuclear magnetic resonance, in combination with other spectroscopic techniques, was used to identify structures.
(1) Ultraviolet spectrum (the solvent is methanol),λ max(logε): 330(3.60), 264 (3.06), 212(3.76)nm；
(2) infrared spectrum (Potassium bromide tablet)ν max: 3422, 3065, 2954, 2768, 1685, 1620, 1542,1438, 1356, 1172, 1280, 1157,1069, 1022cm-1；
HRESIMS shows the molecular ion peak m/z of the inventive compound plus sodium301.0681 [M+Na]+（C14H14NaO6Calculated 301.0688), combined1H and13the C NMR spectrum (FIGS. 2 and 3, data attribution Table-1) gives the formula C14H14O6。
Process for preparing compounds1H and13c NMR spectrum shows that the compound has 14 carbon signals and 13 hydrogen signals, including 1,2,3,6,8-5 substituted naphthalene ring signals [ C-1 (C-1)d C166.9 s），C-2（d C106.8 s），C-3（d C156.2 s），C-4（d C101.5 d），C-4a（d C138.6 s），C-5（d C98.8 d），C-6（d C164.3 s），C-7（d C103.5 d），C-8（d C159.0 s），C-8a（d C105.4 s）; H-4（d H6.49 s）， H-5（d H6.55 d，J=2.2），H-7（d H6.31 d，J=2.2）]A methoxy signal [ OMe ] (d C56.1 q;d H3.81 s)]Three phenolic hydroxyl signals [ Ar-OH-1 ] (d H12.72 s），Ar-OH-3（d H11.89 s），Ar-OH-8（d H11.60 s）]A 3-hydroxypropionyl group [ C-1' ((C-1))d C205.7 s），C-2'（d C42.4 t），C-3'（d C61.7 t）；H2-2'（d H3.36 tJ=6.2），H2-3'（d H4.37 tJ=6.2）]. The infrared spectrum showed hydroxyl (3422 cm)-1) Carbonyl group (1685 cm)-1) And phenyl (1620,1542,1438 cm)-1) The absorption peak of (1). The UV spectrum absorbs at 330,264 and 212 nm indicating the presence of an extended chromophore and aromatic rings. H-4 (6.49 s) and C-2 (C-2) in HMBC spectrad C106.8 s）/ C-3（d C156.2 s）/C-5（d C98.8 d）/C-4a（d C138.6s）/C-8a（d C105.4 s），H-5（6.55 d，J= 2.2) and C-4 (C: (C-4)d C101.5 d）/C-6（d C164.3 s）/C-7（d C103.5 d）/C-4a（d C138.6 s）, H-7（6.31 d，J= 2.2) and C-5 (C: (C-5)d C98.8 d）/C-6（d C164.3 s）/C-8（d C159.0 s）/C-8a（d C105.4 s), the structure of the 5-membered substituted naphthalene ring in the compound was confirmed. H2-2′(δ H3.36) and C-2 (δ C106.8) correlation, confirming the attachment of the 3-hydroxypropionyl group at the C-2 position, OMe (C-2) ((C-2)δ H3.81) and C-6 (Cδ C164.3) correlation, confirming that the methoxy group is attached at the C-6 position, Ar-OH proton: (δ H12.72) and C-1 (C: (1:)δ C166.9)/C-2 (δ C106.8)/ C-8a (δ C105.4) related, Ar-OH proton ((Ar-OH)δ H11.60) and C-7 (δ C103.5)/C-8 (δ C159.0)/ C-8a (δ C105.4) related, Ar-OH proton ((Ar-OH)δ H11.89) and C-2 (Cδ C106.8)/C-3 (δ C156.2)/ C-4 (δ C101.5) correlation confirmed that three phenolic hydroxyl groups were attached at the C-1, C-8 and C-3 positions, respectively. The structure of the compound was thus confirmed.
Example 6
The compounds prepared in examples 2,3 and 4 were all yellow gels, and the determination method was the same as that of example 5, all of which confirmed that the compound prepared in examples 2,3 and 4 was C14H14O6。
Example 7
An activity detection test is carried out on any compound prepared in the embodiment 1-4, and the test conditions are as follows:
the MIC (ug/mL) value of naphthalide C was determined using the broth dilution method.
(1) Preparing an antibacterial agent and a culture medium: dissolving the naphthalene compound to be detected in DMSO to prepare a mother solution with a concentration (2560 mu g/ml), and filtering and sterilizing the mother solution for later use. The prepared MH broth culture medium is sterilized for 30min at 121 ℃ for standby.
(2) The MRSA colonies cultured for 24 hours were prepared into a suspension of 0.5 M.turbidimetric standard. The bacterial suspension was diluted 1: 100 with MH broth to obtain a bacterial solution containing about 1X 106CFU/mL of bacteria for use.
(3) Preparing diluted antibacterial agent and inoculating bacterial liquid, taking 13 sterile test tubes (13X 100 mm), adding 1ml of MH broth into each tube except 1.6ml of MH broth into the 1 st tube, adding 0.4ml of antibacterial agent stock solution (such as 1280 mu g/ml) into the 1 st tube, uniformly mixing, sucking 1ml into the 2 nd tube, uniformly mixing, sucking 1ml into the 3 rd tube, diluting to the 11 th tube in a continuous multiple ratio manner, sucking 1ml from the 11 th tube, discarding, and taking the 12 th tube as a growth control without the medicine. The drug concentrations in each tube were 256, 128, 64, 32, 16, 8, 4, 2,1, 0.5, 0.25 μ g/ml in this order. Then 1ml of the prepared inoculum is added into each tube, the drug concentration of the 1 st tube to the 11 th tube is respectively 128, 64, 32, 16, 8, 4, 2,1, 05, 0.25 and 0.125 mu g/ml, the culture in the dilution tube is transferred into a 96-well plate, each sample is divided into three parallels, DMSO is used as a solvent control, and vancomycin is used as a positive control.
(4) Incubation the inoculated 96-well plate was incubated in a 37 ℃ incubator for 24 h.
(5) And (5) judging a result: the lowest drug concentration that completely inhibited bacterial growth in the wells was the MIC, while there was no significant inhibition of bacteria in the solvent control.
The strains used in the broth microdilution method include Staphylococcus aureus standard strain ATCC25923, methicillin-resistant Staphylococcus aureus standard strain ATCC 43300. The result shows that the naphthalide D can inhibit ATCC25923 and ATCC43300, the MIC of a staphylococcus aureus standard strain ATCC25923 is 4 mu g/ml, the MIC of a methicillin-resistant staphylococcus aureus standard strain ATCC43300 is 8 mu g/ml, the MIC of positive control vancomycin to the ATCC25923 and the MIC of the positive control vancomycin to the ATCC43300 are both 1 mu g/ml, and the naphthalide D can be used as a lead compound for developing methicillin-resistant staphylococcus aureus medicaments.

Claims (6)

1. A naphthalene compound is characterized in that the naphthalene compound is obtained by fermenting, extracting, chromatographing and purifying a Phomopsis fukushi strain, and the molecular formula of the naphthalene compound is C14H14O6The structural formula is as follows:
Figure DEST_PATH_IMAGE001
the compound was named: naphthalide D;
the strain of Phomopsis Fukushii has the preservation number of CCTCC M2017632 and the preservation date of 10 months and 23 days in 2017.
2. A method for preparing the naphthalene compound according to claim 1, which comprises the steps of:
A. solid fermentation: culturing a strain Phomopsis fukushii in a potato glucose agar culture medium at 28 ℃ for 7 days, inoculating the strain to a triangular flask containing 10-100 ml of a liquid seed culture medium and 50-500 ml, performing shake culture at 28 ℃ for 5-10 days under the condition of rotary shake at a rotating speed of 180rpm to obtain a bacterium-containing nutrient medium, and inoculating the bacterium-containing nutrient medium to a rice solid culture medium to perform culture to obtain a fermentation product; the potato glucose agar culture medium is prepared by 200g/L of potatoes, 20g/L of glucose, 20g/L of agar, 6.5 of pH value, sterilization at 121 ℃, 25min, cooling to 60 ℃ and chamfering; the liquid seed culture medium is NaNO32g/L，K2HPO41g/L，MgSO4·7H2O 0.5g/L，KCL 0.5g/L，FeSO4·7H2O0.01 g/L, glucose 20g/L, pH 6.5, placing into 250mL conical flask, 100 mL/flask, sterilizing at 121 deg.C for 25min to obtain; the rice solid cultureThe base is prepared by putting 100g of rice, 20g of perlite and 100mL of distilled water into a 600mL tissue culture bottle, and sterilizing at 121 ℃ for 25 min;
B. extracting the extractum: adding an organic solvent with the solid-liquid volume ratio of 1.5-3 times into the fermentation product, performing ultrasonic extraction for 2-4 times, each time for 4-8 hours, combining the extracting solutions, filtering, performing reduced pressure concentration until the volume is 1/4-1/2, standing, filtering out precipitates, and concentrating to obtain an extract;
C. silica gel column chromatography: performing silica gel column chromatography on the extract, wherein silica gel filled in the column is 200-300 meshes, and the using amount of the silica gel is 6-8 times of the weight of the extract; performing gradient elution by using a chloroform-methanol mixed organic solvent with a volume ratio of 20: 1-1: 1, collecting gradient eluent, concentrating, monitoring by TLC, and combining the same parts;
D. high-pressure liquid chromatography separation and purification: and (3) carrying out separation and purification on an eluent obtained by eluting the mixed organic solvent with the ratio of 6:4 by silica gel column chromatography and preparative high performance liquid chromatography to obtain the target naphthalene compound naphthalide D.
3. The method according to claim 2, wherein the organic solvent in step B is acetone, ethanol or methanol with a volume concentration of 60-80%.
4. The preparation method according to claim 2, wherein the extract in step C is dissolved in 1.5-3 times of acetone before being subjected to silica gel column chromatography, and then is mixed with 1-3 times of 200-300 mesh silica gel.
5. The method according to claim 2, wherein the chloroform-methanol mixed organic solvent is at a volume ratio of 20:1, 9:1, 8:2, 7:3, 6:4, and 5: 5.
6. Use of the naphthalene compound of claim 1 in the preparation of a methicillin-resistant staphylococcus aureus resistant medicament.
CN201711067095.9A 2017-11-03 2017-11-03 Naphthalene compound and preparation method and application thereof Active CN108002999B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711067095.9A CN108002999B (en) 2017-11-03 2017-11-03 Naphthalene compound and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711067095.9A CN108002999B (en) 2017-11-03 2017-11-03 Naphthalene compound and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN108002999A CN108002999A (en) 2018-05-08
CN108002999B true CN108002999B (en) 2020-06-19

Family

ID=62051210

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711067095.9A Active CN108002999B (en) 2017-11-03 2017-11-03 Naphthalene compound and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN108002999B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4305411A (en) * 1978-10-20 1981-12-15 International Flavors & Fragrances Inc. Acetyl hydrindacenes, acetyl indanes, mixtures of same, processes for preparing same and organoleptic uses thereof
CN105884621A (en) * 2016-04-19 2016-08-24 秦瑞欣 Sesquiterpenoids as well as preparation method and application thereof
CN107501065A (en) * 2017-08-24 2017-12-22 云南中烟工业有限责任公司 A kind of multi-substituent naphthalene compounds with antibacterial activity in aloe and preparation method and application

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4305411A (en) * 1978-10-20 1981-12-15 International Flavors & Fragrances Inc. Acetyl hydrindacenes, acetyl indanes, mixtures of same, processes for preparing same and organoleptic uses thereof
CN105884621A (en) * 2016-04-19 2016-08-24 秦瑞欣 Sesquiterpenoids as well as preparation method and application thereof
CN107501065A (en) * 2017-08-24 2017-12-22 云南中烟工业有限责任公司 A kind of multi-substituent naphthalene compounds with antibacterial activity in aloe and preparation method and application

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
拟茎点霉属真菌福士拟茎点霉发酵产物中的1 个具有抗菌活性的新二苯醚类化合物;刑欢欢 等;《中草药》;20180228;第49卷(第4期);第767-771页 *

Also Published As

Publication number Publication date
CN108002999A (en) 2018-05-08

Similar Documents

Publication Publication Date Title
CN115806881B (en) Penicillium fungus and application thereof in preparation of antibacterial drugs
CN104946693B (en) The method and purposes of rheum emodin -8- methyl ether are prepared using ocean aspergillus flavipes HN4-13 bacterial strain
CN109232493A (en) A kind of sesquiterpenoid and its preparation method and application
CN114437011B (en) Chromone compound and preparation method and application thereof
CN108003000B (en) Diphenyl ether compound and preparation method and application thereof
CN108033877B (en) MRSA-resistant naphthalene compound and preparation method thereof
CN108017528B (en) Naphthalene compound and preparation method and application thereof
CN108002999B (en) Naphthalene compound and preparation method and application thereof
CN107815473B (en) Diphenyl ether compound and preparation method and application thereof
CN108002998B (en) Naphthalene compound and preparation method and application thereof
CN114149445B (en) Preparation method of xanthone compound and application of xanthone compound in resisting drug-resistant bacteria
CN102659547B (en) Ophiobolin sesterterpene compound and preparation and application thereof
CN105476983B (en) A kind of purposes of deep-sea originated from fungus compound Prenylcandidusin C
CN106565448B (en) A method of isolating and purifying 7- hydroxy tropolone from bacterial supernatant
CN108441427A (en) A kind of pyridone alkaloid compound of Arthrinium fungi and its production
CN109180593B (en) Phenolic oxazine alkaloid secondary metabolite and application thereof
CN107226800A (en) A kind of xanthone classes compound and its preparation method of monocrystalline and the application as anti-Mycobacterium marinum medicine
CN109575040B (en) Compound with antibacterial activity and preparation method thereof
CN111588717A (en) Application of two quadruple lactone antibiotics as MRSA (methicillin resistant Staphylococcus aureus) resisting drugs and extraction and separation method thereof
CN109971655B (en) Astragalus membranaceus endophytic Chaetomium sp HQ-1 and application thereof
CN113603666B (en) Compound eutyccopalol H and L, preparation method thereof and application thereof in preparation of antibacterial drugs
CN107652262B (en) Preparation method and application of amicumacecin isocoumarin compound
CN112899199B (en) Micromonospora TMD166 and application thereof
CN114525224B (en) Bacillus amyloliquefaciens capable of highly producing antibacterial active substance macrolactinA and application thereof
CN115287236A (en) Preparation method and application of alkaloid compound from insect symbiotic actinomycetes

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant